Facebook
Twitter
Telegram
Report an ErrorClover Health Investments, Corp. Balance Sheet 2011-2024 | CLOV
Annual Balance Sheet Clover Health Investments, Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-118 M | -97.9 M | -277 M | -27.2 M | - | - | - | - | - | - | - | - | - |
Long Term Debt |
3 M | 4.03 M | 19.9 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.66 M | 1.83 M | 3.06 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
261 M | 432 M | 372 M | 33.9 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
284 M | 452 M | 411 M | 62.9 M | 118 K | - | - | - | - | - | - | - | - |
Deferred Revenue |
3.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.16 B | -1.95 B | -1.62 B | -6.76 M | -17.6 K | - | - | - | - | - | - | - | - |
Total Assets |
571 M | 809 M | 951 M | 856 M | 100 K | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
123 M | 104 M | 300 M | 92.3 M | - | - | - | - | - | - | - | - | - |
Book Value |
286 M | 357 M | 540 M | 794 M | -17.6 K | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
286 M | 357 M | 540 M | -613 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Clover Health Investments, Corp.
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.72 M | 3.29 M | 3.61 M | 3.91 M | 4.03 M | 20 M | 20 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 24.3 M | 106 M | 106 M | 106 M | 106 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
379 M | 738 M | 927 M | 1.13 B | 452 M | 1.17 B | 1.64 B | 2.19 B | 411 M | 540 M | 901 M | 278 M | 433 M | 433 M | 433 M | 433 M | 118 K | 118 K | 118 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | 103 M | 114 M | 108 M | - | 96.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.18 B | -2.09 B | -2.05 B | -2.02 B | -1.95 B | -1.87 B | -1.8 B | -1.69 B | -1.62 B | -1.43 B | -1.4 B | -1.08 B | -1.03 B | -1.03 B | -1.03 B | -1.03 B | -17.6 K | -17.6 K | -17.6 K | -17.6 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
672 M | 1.06 B | 1.26 B | 737 M | 809 M | 1.56 B | 2.06 B | 2.68 B | 951 M | 952 M | 1.22 B | 867 M | 267 M | 267 M | 267 M | 267 M | 100 K | 100 K | 100 K | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
208 M | 299 M | 310 M | 191 M | 104 M | 383 M | 324 M | 274 M | 300 M | 202 M | 486 M | 405 M | 92.3 M | 92.3 M | 92.3 M | 92.3 M | 67.6 M | - | - | - | 75.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
292 M | 322 M | 331 M | -393 M | 357 M | 392 M | 427 M | 490 M | 539 M | 412 M | 315 M | 589 M | -165 M | -165 M | -165 M | -165 M | -17.6 K | -17.6 K | -17.6 K | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
292 M | 322 M | 331 M | 323 M | 357 M | 392 M | 427 M | 490 M | 535 M | 412 M | 315 M | 589 M | -613 M | -617 M | -617 M | -617 M | -17.6 K | -17.6 K | -17.6 K | -17.6 K | -503 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency